Company Overview More
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
CEO: McDonald, Damien
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

LIVN LivaNova
66.230+1.180+1.81%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30(Q2)2021/06/30
Assets
Current assets
Cash, cash equivalents and short term investments
-17.74% 207.99M -17.72% 208M -20.18% 181.85M 41.64% 329.39M
-Cash and cash equivalents
-17.74% 207.99M -17.72% 208M -20.18% 181.85M 41.64% 329.39M
Receivables
-8.84% 222.98M -8.83% 223M -7.3% 218.04M -4.15% 218.36M
-Accounts receivable
0.54% 185.35M 0.54% 185.4M -5.15% 182.01M -2.13% 182.18M
-Taxes receivable
-37.55% 37.62M -37.54% 37.6M -16.82% 36.03M -13.15% 36.18M
Inventory
-16.45% 105.84M -16.5% 105.8M -30.52% 123.73M -28.25% 127.17M
Prepaid assets
44.18% 35.75M 43.95% 35.7M -16.28% 26.81M -17.29% 28.82M
Other current assets
-- -- -- 100K -- -- -- --
Total current assets
-5.6% 679.18M -5.59% 679.2M -3.98% 646.36M 20.32% 809.1M
Non current assets
Net PPE
-11.04% 190.67M -11.01% 190.7M -18.25% 198.94M -12.45% 207.31M
-Gross PPE
-5.5% 352.45M -11.01% 190.7M -18.25% 198.94M -12.45% 207.31M
-Accumulated depreciation
-1.99% -161.79M -- -- -- -- -- --
Goodwill and other intangible assets
-4.47% 1.3B -4.46% 1.3B -12.53% 1.31B -9.98% 1.34B
-Goodwill
-2.47% 899.53M -2.47% 899.5M -1.45% 905.15M 1.78% 918.28M
-Other intangible assets
-8.67% 399.68M -8.66% 399.7M -29.95% 408.95M -28.16% 419.18M
Investments and advances
-46.62% 16.6M -46.62% 16.6M -45.39% 16.58M -49.5% 15.28M
Financial assets
-- 0 -- 0 -- 0 -- 0
Non current deferred assets
-26.52% 2.2M -26.67% 2.2M -91.13% 2.01M -91.87% 1.88M
Other non current assets
16.49% 13.1M -84.31% 13.1M -49.12% 25.41M -53.09% 25.5M
Total non current assets
-10.06% 1.52B -10.05% 1.52B -15.77% 1.56B -13.27% 1.59B
Total assets
-8.73% 2.2B -8.73% 2.2B -12.62% 2.2B -4.24% 2.4B
Liabilities
Current liabilities
Payables
4.91% 94.56M -7.87% 83.1M 6.94% 87.39M 10.23% 85.35M
-accounts payable
-7.69% 68M -7.73% 68M -15.85% 60.25M -11.2% 61.33M
-Total tax payable
-8.04% 15.14M -8.48% 15.1M 102.75% 20.51M 120.31% 18.43M
-Other payable
-- 11.42M -- -- -- 6.63M -- 5.6M
Current accrued expenses
-17.17% 55.3M -6.81% 88.9M -6.69% 68.62M 2.03% 72.51M
Current provisions
11.7% 35.38M 14.69% 32.8M -6.61% 36.01M 35.48% 55.75M
Current debt and capital lease obligation
878.65% 240.93M 1627.07% 229.7M 824.36% 239.35M 1211.46% 243.72M
-Current debt
1621.3% 229.67M 1627.07% 229.7M 1532.43% 227.77M 3014.67% 232.01M
-Current capital lease obligation
-0.13% 11.26M -- -- -3.01% 11.58M 5.15% 11.71M
Current deferred liabilities
21.5% 8.42M -- -- 6.1% 8.19M -16.91% 7.84M
Other current liabilities
394.21% 183.11M 516.84% 183.2M 11214.5% 151.39M 9236.15% 174.87M
Current liabilities
125.52% 696.97M 125.49% 697M 133.7% 658.47M 161.68% 702.25M
Non current liabilities
Long term provisions
-- -- -- -- -- -- -39.81% 6.99M
Long term debt and capital lease obligation
-93.31% 45.77M -93.32% 45.7M -92.73% 49.49M -30.49% 473.76M
-Long term debt
-98.47% 9.85M -98.47% 9.8M -98.31% 10.8M -32.57% 431.03M
-Long term capital lease obligation
-14.93% 35.92M -14.93% 35.9M -10.29% 38.69M 0.79% 42.72M
Non current deferred liabilities
-13.31% 7.73M -13.48% 7.7M -70.69% 8.31M -65.25% 10.46M
Employee benefits
-7.38% 19.11M -7.28% 19.1M -21.36% 18.17M -17.87% 18.4M
Derivative product liabilities
-- 0 -- 0 -- 0 -99.72% 200K
Other non current liabilities
-2.05% 136.74M -2% 136.9M 81.12% 156.48M 71.59% 144M
Total non current liabilities
-78.71% 209.34M -78.71% 209.4M -73.86% 232.45M -27.44% 653.8M
Total liabilities
-29.88% 906.31M -29.88% 906.4M -23.92% 890.91M 15.95% 1.36B
Shareholders'equity
Share capital
7.86% 82.3M -- -- 7.75% 82.25M 0.09% 76.41M
-common stock
7.86% 82.3M -- -- 7.75% 82.25M 0.09% 76.41M
Retained earnings
-19.32% -897.78M -- -- -86.14% -879.66M -82.92% -837.42M
Paid-in capital
19.78% 2.12B -- -- 19.84% 2.11B 1.62% 1.78B
Less: Treasury stock
-37.14% 650K -- -- -36.28% 671K -33.3% 705K
Gains losses not affecting retained earnings
-125.81% -7.18M -- -- 130.61% 3.18M 165.76% 23.08M
Total stockholders'equity
15.71% 1.29B 15.71% 1.29B -2.83% 1.31B -21.96% 1.04B
Total equity
15.71% 1.29B 15.71% 1.29B -2.83% 1.31B -21.96% 1.04B
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion------

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%